These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22901750)

  • 21. Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer.
    Saung MT; Muth S; Ding D; Thomas DL; Blair AB; Tsujikawa T; Coussens L; Jaffee EM; Zheng L
    J Immunother Cancer; 2018 Nov; 6(1):118. PubMed ID: 30424804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
    Jiang M; Bennani NN; Feldman AL
    Expert Rev Hematol; 2017 Mar; 10(3):239-249. PubMed ID: 28133975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
    Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
    Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of CD137 in tumor cells of Hodgkin lymphoma from Northern China and its application in pathological differential diagnosis].
    Shi YF; Gao ZF; Liu CL; Huang X; Song YQ; Zhang C; Lin DM; Zhou LX; Zhao M; Lai YM; Li M
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):484-90. PubMed ID: 27431073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.
    Roncador G; García Verdes-Montenegro JF; Tedoldi S; Paterson JC; Klapper W; Ballabio E; Maestre L; Pileri S; Hansmann ML; Piris MA; Mason DY; Marafioti T
    Haematologica; 2007 Aug; 92(8):1059-66. PubMed ID: 17640856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody.
    Nakamura N; Hase H; Sakurai D; Yoshida S; Abe M; Tsukada N; Takizawa J; Aoki S; Kojima M; Nakamura S; Kobata T
    Virchows Arch; 2005 Jul; 447(1):53-60. PubMed ID: 16025281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers.
    Pauly S; Broll K; Wittmann M; Giegerich G; Schwarz H
    J Leukoc Biol; 2002 Jul; 72(1):35-42. PubMed ID: 12101260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclin D2 and D3 in lymphoid lesions.
    Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
    Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas.
    Montes-Moreno S; Roncador G; Maestre L; Martínez N; Sanchez-Verde L; Camacho FI; Cannata J; Martinez-Torrecuadrada JL; Shen Y; Chan WC; Piris MA
    Blood; 2008 Jan; 111(1):351-8. PubMed ID: 17898315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of granulocyte and macrophage populations of murine bone marrow cells by G-CSF and CD137 protein.
    Jiang D; Schwarz H
    PLoS One; 2010 Dec; 5(12):e15565. PubMed ID: 21179444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value.
    Wang T; Lasota J; Hanau CA; Miettinen M
    APMIS; 1995 Sep; 103(9):655-62. PubMed ID: 7488387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.
    Marafioti T; Jabri L; Pulford K; Brousset P; Mason DY; Delsol G
    Br J Haematol; 2003 Feb; 120(4):671-8. PubMed ID: 12588355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of CD137 Immunohistochemical Stain on Paraffin-Embedded Tissue as a Marker to Facilitate Distinction Between Classic Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma, T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, and Anaplastic Large Cell Lymphoma.
    Carbone PN; Zhang QY
    Arch Pathol Lab Med; 2019 Mar; 143(3):280-281. PubMed ID: 30816829
    [No Abstract]   [Full Text] [Related]  

  • 36. CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
    Wong HY; Schwarz H
    J Autoimmun; 2020 Aug; 112():102499. PubMed ID: 32505443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas.
    Dorfman DM; Shahsafaei A; Nadler LM; Freeman GJ
    Am J Pathol; 1998 Jul; 153(1):255-62. PubMed ID: 9665486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional expression of CD137 (4-1BB) on T helper follicular cells.
    Alfaro C; Echeveste JI; Rodriguez-Ruiz ME; Solorzano JL; Perez-Gracia JL; Idoate MA; Lopez-Picazo JM; Sanchez-Paulete AR; Labiano S; Rouzaut A; Oñate C; Aznar A; Lozano MD; Melero I
    Oncoimmunology; 2015 Dec; 4(12):e1054597. PubMed ID: 26587331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.
    Srivastava RM; Trivedi S; Concha-Benavente F; Gibson SP; Reeder C; Ferrone S; Ferris RL
    Clin Cancer Res; 2017 Feb; 23(3):707-716. PubMed ID: 27496866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BT7480, a novel fully synthetic
    Hurov K; Lahdenranta J; Upadhyaya P; Haines E; Cohen H; Repash E; Kanakia D; Ma J; Kristensson J; You F; Campbell C; Witty D; Kelly M; Blakemore S; Jeffrey P; McDonnell K; Brandish P; Keen N
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34725211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.